News

Teva has admitted that its generic drug Neutroval infringes Amgen’s two patents. The two patents at issue in the litigation, US patent nos. 5,580,755 and 5,582,823, expire in

The company intends to send around 30 million doses of its US Food and Drug Administration (FDA) approved seasonal influenza vaccine for the US market. Novartis‘ Fluvirin influenza

CPM ContractPharma, which belongs to Temmler Group, is engaged in manufacturing and processing of solid, semi-solid and liquid pharmaceutical dosage forms. Romaco’s blister lines enable CPM to document

As part of a maintenance contract, MCC has received $50,000 in new, annual business awards from Merck-Schering-Plough. Manufactured by MCC, the tablet press is used for R&D at

The results of the trial demonstrated that AIC316 showed safety and efficacy in patients with genital herpes. In the trial, AIC316 was safe and well tolerated at all

Valeant will pay Janssen $345m for prescription brands like RETIN-A MICRO, ERTACZO and RENOVA. Valeant Pharmaceutical chairman and CEO Michael Pearson said with the combination of this transaction

FlexTouch features easy-touch which enables patients to use little force for injecting the insulin at any dose. The company expects to roll out the insulin pen in EU

The patent allows Arch Biopartners to develop methods to prevent or inhibit the growth of biofilm formation on biotic and abiotic surfaces. The method modifies solid surfaces to

The results of the trial demonstrated that patients with HER2-positive metastatic breast cancer (mBC) who have been administered combined medicine of pertuzumab and Herceptin (trastuzumab), in addition to